Loading…

LP-211 is a brain penetrant selective agonist for the serotonin 5-HT7 receptor

We have determined the pharmacological profile of the new serotonin 5-HT 7 receptor agonist N -(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide (LP-211). Radioligand binding assays were performed on a panel of 5-HT receptor subtypes. The compound was also evaluated in vivo by examining it...

Full description

Saved in:
Bibliographic Details
Published in:Neuroscience letters 2010-08, Vol.481 (1), p.12-16
Main Authors: HEDLUND, Peter B, LEOPOLDO, Marcello, CACCIA, Silvio, SARKISYAN, Gor, FRACASSO, Claudia, MARTELLI, Giuliana, LACIVITA, Enza, BERARDI, Francesco, PERRONE, Roberto
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We have determined the pharmacological profile of the new serotonin 5-HT 7 receptor agonist N -(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide (LP-211). Radioligand binding assays were performed on a panel of 5-HT receptor subtypes. The compound was also evaluated in vivo by examining its effect on body temperature regulation in mice lacking the 5-HT 7 receptor (5-HT 7 −/− ) and their 5-HT 7 +/+ sibling controls. Disposition studies were performed in mice of both genotypes. It was found that LP-211 was brain penetrant and underwent metabolic degradation to 1-(2-diphenyl)piperazine (RA-7). In vitro binding assays revealed that RA-7 possessed higher 5-HT 7 receptor affinity than LP-211 and a better selectivity profile over a panel of 5-HT receptor subtypes. In vivo it was demonstrated that LP-211, and to a lesser degree RA-7, induced hypothermia in 5-HT 7 +/+ but not in 5-HT 7 −/− mice. Our results suggest that LP-211 can be used as a 5-HT 7 receptor agonist in vivo .
ISSN:0304-3940
1872-7972
DOI:10.1016/j.neulet.2010.06.036